Literature DB >> 19278895

Peroxo and oxo intermediates in mononuclear nonheme iron enzymes and related active sites.

Edward I Solomon1, Shaun D Wong, Lei V Liu, Andrea Decker, Marina S Chow.   

Abstract

Fe(III)OOH and Fe(IV)O intermediates have now been documented in a number of nonheme iron active sites. In this Current Opinion we use spectroscopy combined with electronic structure calculations to define the frontier molecular orbitals (FMOs) of these species and their contributions to reactivity. For the low-spin Fe(III)OOH species in activated bleomycin we show that the reactivity of this nonheme iron intermediate is very different from that of the analogous Compound 0 of cytochrome P450. For Fe(IV)O S=1 model species we experimentally define the electronic structure and its contribution to reactivity, and computationally evaluate how this would change for the Fe(IV)O S=2 intermediates found in nonheme iron enzymes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19278895      PMCID: PMC2676221          DOI: 10.1016/j.cbpa.2009.02.011

Source DB:  PubMed          Journal:  Curr Opin Chem Biol        ISSN: 1367-5931            Impact factor:   8.822


  37 in total

1.  Cleavage of Nucleic Acids by Bleomycin.

Authors:  Richard M. Burger
Journal:  Chem Rev       Date:  1998-05-07       Impact factor: 60.622

Review 2.  Bleomycin: new perspectives on the mechanism of action.

Authors:  S M Hecht
Journal:  J Nat Prod       Date:  2000-01       Impact factor: 4.050

3.  Two-state reactivity in alkane hydroxylation by non-heme iron-oxo complexes.

Authors:  Hajime Hirao; Devesh Kumar; Lawrence Que; Sason Shaik
Journal:  J Am Chem Soc       Date:  2006-07-05       Impact factor: 15.419

4.  Spectroscopic evidence for a high-spin Br-Fe(IV)-oxo intermediate in the alpha-ketoglutarate-dependent halogenase CytC3 from Streptomyces.

Authors:  Danica Galonić Fujimori; Eric W Barr; Megan L Matthews; Gretchen M Koch; J Ryan Yonce; Christopher T Walsh; J Martin Bollinger; Carsten Krebs; Pamela J Riggs-Gelasco
Journal:  J Am Chem Soc       Date:  2007-10-16       Impact factor: 15.419

Review 5.  Nuclear resonance vibrational spectroscopy--NRVS.

Authors:  W Robert Scheidt; Stephen M Durbin; J Timothy Sage
Journal:  J Inorg Biochem       Date:  2005-01       Impact factor: 4.155

6.  Spectroscopic and electronic structure studies of aromatic electrophilic attack and hydrogen-atom abstraction by non-heme iron enzymes.

Authors:  Michael L Neidig; Andrea Decker; Oliver W Choroba; Fanglu Huang; Michael Kavana; Graham R Moran; Jonathan B Spencer; Edward I Solomon
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-18       Impact factor: 11.205

7.  Spectroscopic properties and electronic structure of low-spin Fe(III)-alkylperoxo complexes: homolytic cleavage of the O-O bond.

Authors:  N Lehnert; R Y Ho; L Que; E I Solomon
Journal:  J Am Chem Soc       Date:  2001-08-29       Impact factor: 15.419

8.  Electronic structure and reactivity of low-spin Fe(III)-hydroperoxo complexes: comparison to activated bleomycin.

Authors:  Nicolai Lehnert; Frank Neese; Raymond Y N Ho; Lawrence Que; Edward I Solomon
Journal:  J Am Chem Soc       Date:  2002-09-11       Impact factor: 15.419

9.  Activated bleomycin. A transient complex of drug, iron, and oxygen that degrades DNA.

Authors:  R M Burger; J Peisach; S B Horwitz
Journal:  J Biol Chem       Date:  1981-11-25       Impact factor: 5.157

10.  Further insights into the mechanism of the reaction of activated bleomycin with DNA.

Authors:  Marina S Chow; Lei V Liu; Edward I Solomon
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-29       Impact factor: 11.205

View more
  28 in total

1.  Dichotomous hydrogen atom transfer vs proton-coupled electron transfer during activation of X-H bonds (X = C, N, O) by nonheme iron-oxo complexes of variable basicity.

Authors:  Dandamudi Usharani; David C Lacy; A S Borovik; Sason Shaik
Journal:  J Am Chem Soc       Date:  2013-11-04       Impact factor: 15.419

Review 2.  Transition-metal ions in zeolites: coordination and activation of oxygen.

Authors:  Pieter J Smeets; Julia S Woertink; Bert F Sels; Edward I Solomon; Robert A Schoonheydt
Journal:  Inorg Chem       Date:  2010-04-19       Impact factor: 5.165

3.  Structure and reactivity of a mononuclear non-haem iron(III)-peroxo complex.

Authors:  Jaeheung Cho; Sujin Jeon; Samuel A Wilson; Lei V Liu; Eun A Kang; Joseph J Braymer; Mi Hee Lim; Britt Hedman; Keith O Hodgson; Joan Selverstone Valentine; Edward I Solomon; Wonwoo Nam
Journal:  Nature       Date:  2011-10-26       Impact factor: 49.962

4.  O2 Activation by Non-Heme Iron Enzymes.

Authors:  Edward I Solomon; Serra Goudarzi; Kyle D Sutherlin
Journal:  Biochemistry       Date:  2016-11-14       Impact factor: 3.162

Review 5.  The biology and chemistry of high-valent iron-oxo and iron-nitrido complexes.

Authors:  Johannes Hohenberger; Kallol Ray; Karsten Meyer
Journal:  Nat Commun       Date:  2012-03-06       Impact factor: 14.919

6.  Characterization of the Earliest Intermediate of Fe-N2 Protonation: CW and Pulse EPR Detection of an Fe-NNH Species and Its Evolution to Fe-NNH2.

Authors:  Mark A Nesbit; Paul H Oyala; Jonas C Peters
Journal:  J Am Chem Soc       Date:  2019-05-14       Impact factor: 15.419

7.  Role of metal-oxo complexes in the cleavage of C-H bonds.

Authors:  A S Borovik
Journal:  Chem Soc Rev       Date:  2011-03-01       Impact factor: 54.564

8.  Nonheme oxo-iron(IV) intermediates form an oxyl radical upon approaching the C-H bond activation transition state.

Authors:  Shengfa Ye; Frank Neese
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-10       Impact factor: 11.205

9.  Reactivities of Fe(IV) complexes with oxo, hydroxo, and alkylperoxo ligands: an experimental and computational study.

Authors:  Adam T Fiedler; Lawrence Que
Journal:  Inorg Chem       Date:  2009-12-07       Impact factor: 5.165

10.  Tuning the Relative Stability and Reactivity of Manganese Dioxygen and Peroxo Intermediates via Systematic Ligand Modification.

Authors:  Julie A Kovacs
Journal:  Acc Chem Res       Date:  2015-09-03       Impact factor: 22.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.